Status: Phase 2
Entry Type: Antibody
Molecule Category: UNKNOWN

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Tumor necrosis factor receptor superfamily member 5 inhibitor

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Arthritis, Psoriatic 1 D015535 ClinicalTrials
Obesity 1 D009765 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL2109475